Pioglitazole and metformin hydrochloride 15 mg/1

Pioglitazone and metformin hydrochloride 15 mg/1 tablets combine two antidiabetic agents for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Pioglitazone and metformin hydrochloride tablets are commonly used to manage type 2 diabetes. These tablets work by improving insulin sensitivity and reducing glucose production in the liver. They are often prescribed when diet and exercise alone are not sufficient to control blood sugar levels. This combination therapy may be used alongside other diabetes medications as part of a comprehensive treatment strategy.

Common effects of pioglitazone and metformin hydrochloride tablets may include gastrointestinal discomfort, such as nausea or diarrhea. Some users may experience weight gain or fluid retention. These effects vary among individuals and typically subside as the body adjusts to the medication.

Handle pioglitazone and metformin hydrochloride tablets with care, especially if you have a history of liver or kidney issues. Regular monitoring of blood sugar levels is advisable. Consult a healthcare provider before starting this medication, particularly if you are pregnant, breastfeeding, or have other medical conditions.

Pioglitazone and metformin hydrochloride tablets may interact with certain medications, including other diabetes drugs, steroids, and some antibiotics. Alcohol consumption should be avoided as it can affect blood sugar levels and increase the risk of lactic acidosis. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.